MilliporeSigma MilliporeSigma Licenses CRISPR-Cas9 Technology to Cellecta Cellecta said it will use MilliporeSigma's technology to offer its customers CRISPR-mediated targeted gene knock-in services. Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test The diagnostic is composed of Agilent's Bravo automation workstation and Mammoth's DETECTR BOOST SARS-CoV-2 assay. Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company The CRISPR-based test uses Mammoth's DETECTR BOOST platform and will be compatible with both nasal swab and saliva samples. 10x Genomics, MilliporeSigma Collaborate on CRISPR Screening Workflow The firms are targeting a compatible offering for single-cell gene expression screens following CRISPR-based editing, with applications in drug discovery. MilliporeSigma's New CRISPR System Moves Chromatin Out of Way for More Efficient Editing Premium The company's CRISPR-chrom technology fuses chromatin-modulating peptides to CRISPR nucleases, essentially moving chromatin out of the way for more efficient editing. Dec 19, 2019 MilliporeSigma Licenses CRISPR Tech to Promega Jul 31, 2019 CRISPR Patent Pools Pop Up, But Participation Uncertain as IP Holders Continue Legal Battles Premium Jul 18, 2019 Broad Institute, MilliporeSigma Create CRISPR IP License Framework Jan 14, 2019 Roche, MilliporeSigma Renew PCR Products Distribution Agreement Oct 18, 2018 Luminex to Pay $75M for MilliporeSigma's Flow Cytometry Research Portfolio Apr 11, 2017 MilliporeSigma Developing New Instrument for Single-Molecule Biomarker Detection Premium May 19, 2016 CRISPR/Cas9 Takes Root in Core Facilities Worldwide Premium Mar 8, 2016 Merck KGaA's 2015 Sales Jump on Life Sciences Contribution, Sigma-Aldrich Acquisition Dec 30, 2015 M&A Deals in MDx/Omics Life Sciences Tools Space Up 33 Percent in 2015 Nov 18, 2015 Merck KGaA Completes $17B Sigma-Aldrich Acquisition Nov 3, 2015 Sigma-Aldrich Q3 Revenues Rise 2 Percent as Firm Nears Closure of Merck Deal Oct 29, 2015 Sigma-Aldrich Acquiring Olink's Duolink Line Oct 27, 2015 Sigma-Aldrich Joins UCSF Technology Development Program Oct 20, 2015 Honeywell to Buy Sigma-Aldrich's Research Chemicals Business for €104 million Oct 19, 2015 Sigma-Aldrich Inks Deal to Manufacture, Distribute Sanger Institute's CRISPR Knock-Out Libraries Sep 17, 2015 Sigma-Aldrich Inks Exclusive Distribution Deal with IROA Technologies Aug 11, 2015 Brazil Clears Merck KGaA's Buy of Sigma-Aldrich Aug 5, 2015 Sigma-Aldrich to Distribute LGC KASP Genotyping Assays Jul 30, 2015 Currency Effects Trim Sigma-Aldrich Q2 Sales Jul 23, 2015 Sigma-Aldrich Facilities Gain ISO Certification Load More Breaking News UK Biobank Study Investigates Incomplete Penetrance of Mendelian Disease Variants MDxHealth Q3 Revenues Grow 23 Percent BioMérieux Q3 Revenues Increase 11 Percent, Firm Raises 2021 Guidance Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates Horse Genetics Study Reveals Origins of Domestication, Use in Human Culture The Scan Guidelines for Ancient DNA Work More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature. And Cleared A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times. Suit Over Allegations The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director. Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.